- Home
- ICCT vs SCNI Comparison
ICCT vs SCNI Comparison
Compare ICCT & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- SCNI
- Stock Information
- Founded
- ICCT 1992
- SCNI 2003
- Country
- ICCT United States
- SCNI Israel
- Employees
- ICCT N/A
- SCNI N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICCT Technology
- SCNI Health Care
- Exchange
- ICCT Nasdaq
- SCNI Nasdaq
- Market Cap
- ICCT 2.9M
- SCNI 3.1M
- IPO Year
- ICCT N/A
- SCNI N/A
- Fundamental
- Price
- ICCT $2.50
- SCNI $3.51
- Analyst Decision
- ICCT
- SCNI
- Analyst Count
- ICCT 0
- SCNI 0
- Target Price
- ICCT N/A
- SCNI N/A
- AVG Volume (30 Days)
- ICCT 142.3K
- SCNI 8.1K
- Earning Date
- ICCT 11-19-2024
- SCNI 11-22-2024
- Dividend Yield
- ICCT N/A
- SCNI N/A
- EPS Growth
- ICCT N/A
- SCNI N/A
- EPS
- ICCT N/A
- SCNI 8.20
- Revenue
- ICCT $11,049,477.00
- SCNI $452,000.00
- Revenue This Year
- ICCT N/A
- SCNI N/A
- Revenue Next Year
- ICCT N/A
- SCNI N/A
- P/E Ratio
- ICCT N/A
- SCNI $0.43
- Revenue Growth
- ICCT 42.66
- SCNI N/A
- 52 Week Low
- ICCT $2.25
- SCNI $2.23
- 52 Week High
- ICCT $37.40
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- ICCT 42.24
- SCNI 52.75
- Support Level
- ICCT $2.25
- SCNI $3.41
- Resistance Level
- ICCT $2.52
- SCNI $3.80
- Average True Range (ATR)
- ICCT 0.19
- SCNI 0.18
- MACD
- ICCT 0.05
- SCNI -0.00
- Stochastic Oscillator
- ICCT 36.23
- SCNI 36.42
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.